| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Oncotelic Therapeutics, Inc. (OTLC) has 1 insider with recent SEC Form 4 filings, including 12 buys and 0 sells. OTLC is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 93.63M | $4.68M | +335.8K |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 6, 2022 | Trieu Vuong | Chairman And CEO | Buy | 120,000 | $0.05 | $6,000.00 | +0.1% | |
| Nov 22, 2022 | Trieu Vuong | Chairman And CEO | Buy | 70,000 | $0.08 | $5,600.00 | - | |
| Sep 26, 2022 | Trieu Vuong | Chairman And CEO | Buy | 20,000 | $0.07 | $1,360.00 | - | |
| Aug 25, 2022 | Trieu Vuong | Chairman And CEO | Buy | 80,000 | $0.08 | $6,560.00 | - | |
| Nov 24, 2020 | Shah Amit B. | Chief Financial Officer | Buy | 60,000 | $0.19 | $11,558.46 | +71.9% | |
| Nov 19, 2020 | Park Chulho | Chief Technology Officer | Buy | 22,173 | $0.18 | $4,097.57 | +0.8% | |
| Nov 19, 2020 | Trieu Vuong | Chief Executive Officer | Buy | 50,500 | $0.19 | $9,595.00 | +0.3% | |
| Mar 26, 2020 | Trieu Vuong | Chief Executive Officer | Buy | 3,000 | $0.12 | $360.00 | - | |
| Apr 12, 2018 | Reynolds Donald Rogers | Director | Buy | 250,000 | $0.00 | - | +833.3% | |
| Apr 12, 2018 | Schwieterman William D | President And CEO | Buy | 625,000 | $0.00 | - | +83,668% |